PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)-Reference-Cited by-同舟云学术

PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)

Published:2023-03-01 Issue:4 Volume:62 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Tang Quanying¹,Zhao Shikang¹,Zhou Ning¹,He Jinling¹,Zu Lingling¹,Liu Tingwen¹,Song Zuoqing¹,Chen Jun¹,Peng Ling²,Xu Song¹

Affiliation:

1. Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China

2. Department of Respiratory Disease, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study;Annals of Surgical Oncology;2024-08-23

2. Agent-Based Modeling of Virtual Tumors Reveals the Critical Influence of Microenvironmental Complexity on Immunotherapy Efficacy;Cancers;2024-08-23

3. Pathological examination of factors involved in PD-L1 expression in patients with oral tongue squamous cell carcinoma;Maxillofacial Plastic and Reconstructive Surgery;2024-08-08

4. Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study;Targeted Oncology;2024-05

5. Non‑coding RNA: A promising diagnostic biomarker and therapeutic target for esophageal squamous cell carcinoma (Review);Oncology Letters;2024-04-09